Chengdu Olymvax Biopharmaceuticals Inc(688319) was surveyed by 25 institutions on March 15, 2022. Among them, there are 8 asset management companies, 8 investment companies, 6 fund management companies and 2 securities companies.
Chengdu Olymvax Biopharmaceuticals Inc(688319) was surveyed by 25 institutions on March 15, 2022. Among them, there are 8 asset management companies, 8 investment companies, 6 fund management companies and 2 securities companies.